Benzinga · Oct 19, 2026
Wells Fargo Maintains Equal-Weight on National Health Investors, Lowers Price Target to $68
Wells Fargo analyst James Feldman maintains National Health Investors (NYSE:NHI) with a Equal-Weight and lowers the price target from $78 to $68.

